NM_000132.4:c.121G>A
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 5P and 3B. PM1PM5PP2BP4_ModerateBS2_Supporting
The NM_000132.4(F8):c.121G>A(p.Gly41Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000273 in 1,097,653 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G41C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000132.4 missense
Scores
Clinical Significance
Conservation
Publications
- hemophilia AInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- mild hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- moderately severe hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- severe hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- symptomatic form of hemophilia A in female carriersInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000132.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| F8 | NM_000132.4 | MANE Select | c.121G>A | p.Gly41Ser | missense | Exon 1 of 26 | NP_000123.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| F8 | ENST00000360256.9 | TSL:1 MANE Select | c.121G>A | p.Gly41Ser | missense | Exon 1 of 26 | ENSP00000353393.4 | ||
| F8 | ENST00000453950.1 | TSL:3 | c.103G>A | p.Gly35Ser | missense | Exon 2 of 5 | ENSP00000389153.1 | ||
| F8 | ENST00000647125.1 | n.121G>A | splice_region non_coding_transcript_exon | Exon 1 of 14 | ENSP00000496062.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD2 exomes AF: 0.0000109 AC: 2AN: 182769 AF XY: 0.0000149 show subpopulations
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1097653Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 2AN XY: 363109 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
F8-related disorder Uncertain:1
The F8 c.121G>A variant is predicted to result in the amino acid substitution p.Gly41Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0052% of alleles in individuals of South Asian descent in gnomAD including 1 hemizygous. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at